Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?

Sokolov BP.

Int J Neuropsychopharmacol. 2007 Aug;10(4):547-55. Epub 2007 Feb 12. Review.

PMID:
17291372
2.

Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia.

Haroutunian V, Davis KL.

Int J Neuropsychopharmacol. 2007 Aug;10(4):499-502.

PMID:
17583597
3.

Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction.

Feng Y.

Neurochem Res. 2008 Oct;33(10):1940-9. doi: 10.1007/s11064-008-9693-x. Epub 2008 Apr 11. Review.

PMID:
18404371
4.

Oligodendrocyte pathophysiology: a new view of schizophrenia.

Segal D, Koschnick JR, Slegers LH, Hof PR.

Int J Neuropsychopharmacol. 2007 Aug;10(4):503-11. Epub 2007 Feb 12. Review.

PMID:
17291369
6.

Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia.

Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL.

Int J Neuropsychopharmacol. 2007 Aug;10(4):565-73. Epub 2007 Feb 12.

PMID:
17291370
7.

Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.

Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI.

Schizophr Res. 2004 Apr 1;67(2-3):269-75.

PMID:
14984887
8.

Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin.

Albertson DN, Pruetz B, Schmidt CJ, Kuhn DM, Kapatos G, Bannon MJ.

J Neurochem. 2004 Mar;88(5):1211-9.

9.

Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: a regenerative attempt to compensate oligodendrocyte loss?

Mosebach J, Keilhoff G, Gos T, Schiltz K, Schoeneck L, Dobrowolny H, Mawrin C, Müller S, Schroeter ML, Bernstein HG, Bogerts B, Steiner J.

J Psychiatr Res. 2013 Aug;47(8):1069-79. doi: 10.1016/j.jpsychires.2013.03.018. Epub 2013 Apr 21.

PMID:
23615187
10.

Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder.

Barley K, Dracheva S, Byne W.

Schizophr Res. 2009 Jul;112(1-3):54-64. doi: 10.1016/j.schres.2009.04.019. Epub 2009 May 17.

PMID:
19447584
11.

White matter and cognitive function in schizophrenia.

Dwork AJ, Mancevski B, Rosoklija G.

Int J Neuropsychopharmacol. 2007 Aug;10(4):513-36. Epub 2007 Feb 21. Review.

PMID:
17313699
12.

Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder.

Miyata S, Hattori T, Shimizu S, Ito A, Tohyama M.

Biomed Res Int. 2015;2015:492367. doi: 10.1155/2015/492367. Epub 2015 Feb 1. Review.

13.

Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes.

Katsel P, Davis KL, Li C, Tan W, Greenstein E, Kleiner Hoffman LB, Haroutunian V.

Neuropsychopharmacology. 2008 Nov;33(12):2993-3009. doi: 10.1038/npp.2008.19. Epub 2008 Mar 5.

14.

Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.

Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH.

Neuropsychopharmacology. 2007 Sep;32(9):1888-902. Epub 2007 Feb 14.

15.

Expression of transcripts for myelin related genes in postmortem brain from cocaine abusers.

Kristiansen LV, Bannon MJ, Meador-Woodruff JH.

Neurochem Res. 2009 Jan;34(1):46-54. doi: 10.1007/s11064-008-9655-3. Epub 2008 Mar 21.

16.

White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V.

Arch Gen Psychiatry. 2003 May;60(5):443-56. Review.

PMID:
12742865
17.

Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?

Konrad A, Winterer G.

Schizophr Bull. 2008 Jan;34(1):72-92. Epub 2007 May 7. Review.

18.

Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia.

Stewart DG, Davis KL.

Int Rev Neurobiol. 2004;59:381-424. Review. No abstract available.

PMID:
15006496
19.

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S.

Lancet. 2003 Sep 6;362(9386):798-805.

PMID:
13678875
20.

The role of oligodendrocyte pathology in schizophrenia.

Uranova NA, Vostrikov VM, Vikhreva OV, Zimina IS, Kolomeets NS, Orlovskaya DD.

Int J Neuropsychopharmacol. 2007 Aug;10(4):537-45. Epub 2007 Feb 21.

PMID:
17313698
Items per page

Supplemental Content

Write to the Help Desk